{"id":1328,"date":"2019-09-06T15:26:38","date_gmt":"2019-09-06T15:26:38","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1328"},"modified":"2026-02-24T00:30:32","modified_gmt":"2026-02-24T00:30:32","slug":"predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/","title":{"rendered":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi)"},"content":{"rendered":"

Precision medicin requires the knowledge of constitutive factors of idiosyncratic resilience\/vulnerability of a subject to a disease as a prerequisite for a tailored treatment. Phenylketonuria (PKU), a prototypical model of a treatable genetic disorder, has taught us how variable may be the clinical phenotype caused by a monogenic lesion. We are now aware that the biomarkers adopted so far for diagnosis and monitoring of early treated PKU patients are weakly predictive of the outcome in adulthood, leaving unexplained a wide clinical interindividual variability. With new effective (and expensive) treatments on the horizon this gap needs to be bridged. (https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/03\/jmedgenet-2019-106278<\/a>)<\/p>\n","protected":false},"excerpt":{"rendered":"

Precision medicin requires the knowledge of constitutive factors of idiosyncratic resilience\/vulnerability of a subject to a disease as a prerequisite for a tailored treatment. Phenylketonuria (PKU), a prototypical model of a treatable genetic disorder, has taught us how variable may be the clinical phenotype caused by a monogenic lesion. We are now aware that the […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1328","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nPredictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Precision medicin requires the knowledge of constitutive factors of idiosyncratic resilience\/vulnerability of a subject to a disease as a prerequisite for a tailored treatment. Phenylketonuria (PKU), a prototypical model of a treatable genetic disorder, has taught us how variable may be the clinical phenotype caused by a monogenic lesion. We are now aware that the [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-06T15:26:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:30:32+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi)\",\"datePublished\":\"2019-09-06T15:26:38+00:00\",\"dateModified\":\"2026-02-24T00:30:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/\"},\"wordCount\":131,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/\",\"name\":\"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2019-09-06T15:26:38+00:00\",\"dateModified\":\"2026-02-24T00:30:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/06\\\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/","og_locale":"en_US","og_type":"article","og_title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog","og_description":"Precision medicin requires the knowledge of constitutive factors of idiosyncratic resilience\/vulnerability of a subject to a disease as a prerequisite for a tailored treatment. Phenylketonuria (PKU), a prototypical model of a treatable genetic disorder, has taught us how variable may be the clinical phenotype caused by a monogenic lesion. We are now aware that the [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/","og_site_name":"JMG Contact blog","article_published_time":"2019-09-06T15:26:38+00:00","article_modified_time":"2026-02-24T00:30:32+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi)","datePublished":"2019-09-06T15:26:38+00:00","dateModified":"2026-02-24T00:30:32+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/"},"wordCount":131,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/","url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/","name":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2019-09-06T15:26:38+00:00","dateModified":"2026-02-24T00:30:32+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/06\/predictability-and-inconsistencies-of-cognitive-outcome-in-patients-with-phenylketonuria-and-personalized-therapy-the-challenge-for-the-future-guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalized therapy: the challenge for the future guidelines (Contributed by Prof. Vincenzo Leuzzi)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1328"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1328\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}